Pneumococcal conjugate second or third-dose vaccines (PCVc) in Solomon Islands
Solomon Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 88.0% in 2025. ◆ Volatile
Latest (2025)
88.0%
Change on year
unchanged
World rank
81st
of 194 countries
All-time high
94.0%
in 2019
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Solomon Islands, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Solomon Islands stood at 88.0%.
The figure is up 109.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Solomon Islands peaked at 94.0% in 2019 and was at its lowest, 0.0%, in 2008.
Solomon Islands ranks 81st of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Solomon Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 42.0% | — |
| 2016 | 87.0% | +107.1% |
| 2017 | 81.0% | -6.9% |
| 2018 | 84.0% | +3.7% |
| 2019 | 94.0% | +11.9% |
| 2020 | 93.0% | -1.1% |
| 2021 | 86.0% | -7.5% |
| 2022 | 89.0% | +3.5% |
| 2023 | 81.0% | -9.0% |
| 2024 | 88.0% | +8.6% |
| 2025 | 88.0% | +0.0% |
Solomon Islands compared with similar countries
- Solomon Islands's 88.0% is above the median for lower middle income countries, which is 84.0%, 1.0× the median. (47 countries reporting)
- Solomon Islands's 88.0% is above the median for East Asia & Pacific, which is 81.0%, 1.1× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 38.8% | 0.0% | 94.0% | 10 |
| 2020s | 87.5% | 81.0% | 93.0% | 6 |
Countries ranked near Solomon Islands
More health data for Solomon Islands
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8993 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 863.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 106 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.33 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0612 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.35 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Solomon Islands?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Solomon Islands was 88.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Solomon Islands?
- The highest recorded value was 94.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Solomon Islands?
- The lowest recorded value was 0.0% in 2008.
- How does Solomon Islands rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Solomon Islands ranks 81st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Solomon Islands?
- Over the last ten years it is up 109.5%. The long-run trend across the full record is volatile.
- Where does this Solomon Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).